Asia-Pacific (APAC) Medical Devices Industry Outlook 2023
Disruptive Technology Adoption and Transformative Mega Trends Pave the Way for Innovations
18-Apr-2023
Asia Pacific
Market Outlook
K88C-01-00-00-00
HC03656-AP-MO_27581
While the United States and Europe medical device markets face backlash from the economic slowdown, the Russia-Ukraine war, and the cost-of-living crisis, the APAC medical devices market continues to record phenomenal growth. However, 2023 will be challenging for APAC medtech due to uncertainties arising from the anticipated market slowdown and other macroeconomic factors. Bank failures in the United States also continue to create ripple effects in APAC, with Credit Suisse being the latest.
In this study, Frost & Sullivan analyzes the APAC medical devices market, including macroeconomic factors, the latest trends, revenue forecasts, and predictions. The study period is 2022–2027 and the forecast period is 2023–2027, with 2022 as the base year. We also provide country-specific analyses for China, India, Japan, South Korea, and the rest of APAC. Medical device segments covered include orthopedics, cardiology, respiratory, diabetes, wound care, and others. The study excludes the refurbished medical devices market in APAC.
Our analysis shows that a long-term change that will impact the industry is sustainability. Although lagging in sustainability efforts compared to global counterparts, medtech players in APAC are getting back on track to achieve 2030 Sustainable Development Goals, some even aiming for 2025 or 2027 to achieve carbon neutrality.
The digitalization of medical devices will continue, with original equipment manufacturers digitalizing their devices and operations. This also pushes medtech participants to deliver value for providers and patients with devices and digital data, leading to new business models and disruptive technologies.
As APAC transitions conventional approaches to healthcare innovation, it involves an extensive coalition of healthcare stakeholders. This enables the exploration of new methods that combine diagnostics, devices, digital tools, emerging technologies, and medication to deliver improved patient outcomes.
Frost & Sullivan offers stakeholders insights into opportunities that arise from the increased inclusiveness of underserved patient populations, robotics adoption, and the transition of care from hospitals to home-based models.
Author: Suchismita Das
Market Highlights
Global GDP Growth Snapshot
Top Predictions for 2023
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the APAC Medical Devices Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Market Segmentation
Growth Environment
Growth Environment (continued)
Impact Analysis—Supply Chain Disruptions
Impact Analysis— Sustainability Initiatives
Revenue Forecast by Segment
Revenue Forecast by Segment (continued)
Revenue Forecast by Segment (continued)
Prediction 1
Prediction 2
Prediction 3
Prediction 4
Prediction 5
Snapshot—Orthopedics
Companies to Watch—Orthopedics
Snapshot—Cardiology
Companies to Watch—Cardiology
Snapshot—Respiratory
Companies to Watch—Respiratory
Snapshot—Diabetes
Companies to Watch—Diabetes
Snapshot—Wound Care
Companies to Watch—Wound Care
Snapshot—Others
Companies to Watch—Others
Revenue Forecast by Region
China
India
Japan
South Korea
Rest of APAC
Growth Opportunity 1—Robotic Surgery
Growth Opportunity 1—Robotic Surgery (continued)
Growth Opportunity 2—Transition of Care to Outside the Hospital
Growth Opportunity 2—Transition of Care to Outside the Hospital (continued)
Growth Opportunity 3—Screening Solutions for Cervical and Ovarian Cancers
Growth Opportunity 3—Screening Solutions for Cervical and Ovarian Cancers (continued)
Conclusions and Future Outlook
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
- GDP Growth Rate, Selected Economies, 2022–2023
- Medical Devices: Implications for Stakeholders, APAC, 2022 and 2023
- Medical Devices: Revenue Forecast by Segment, Asia-Pacific, 2022 and 2023
- Medical Devices: Revenue Forecast by Region, APAC, 2022–2027
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
19 Nov 2026 | Global | Technology Research
Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms
Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.